Labcorp Holdings Inc. (LH) To Go Ex-Dividend on May 29th

Labcorp Holdings Inc. (NYSE:LH – Get Free Report) declared a quarterly dividend on Thursday, April 9th. Stockholders of record on Friday, May 29th will be paid a dividend of 0.72 per share by the medical research company on Thursday, June 11th. This represents a c) annualized dividend and a dividend yield of 1.1%. The ex-dividend date of this dividend is Friday, May 29th.

Labcorp has a payout ratio of 16.4% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect Labcorp to earn $19.37 per share next year, which means the company should continue to be able to cover its $2.88 annual dividend with an expected future payout ratio of 14.9%.

Get Labcorp alerts:

Labcorp Trading Down 0.4%

Shares of LH stock opened at $258.91 on Wednesday. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.73 and a quick ratio of 1.54. The company has a market cap of $21.23 billion, a price-to-earnings ratio of 22.93, a PEG ratio of 1.82 and a beta of 0.91. The stock has a 50 day simple moving average of $263.65 and a 200-day simple moving average of $265.72. Labcorp has a 1-year low of $241.81 and a 1-year high of $293.72.

Labcorp (NYSE:LH – Get Free Report) last announced its earnings results on Thursday, April 30th. The medical research company reported $4.25 earnings per share for the quarter, topping the consensus estimate of $4.09 by $0.16. The business had revenue of $3.54 billion during the quarter, compared to the consensus estimate of $3.51 billion. Labcorp had a return on equity of 16.29% and a net margin of 6.66%.The business’s quarterly revenue was up 5.8% on a year-over-year basis. During the same period in the prior year, the company posted $3.84 EPS. Labcorp has set its FY 2026 guidance at 17.700-18.350 EPS. On average, equities research analysts expect that Labcorp will post 17.99 EPS for the current fiscal year.

About Labcorp

(Get Free Report)

Laboratory Corporation of America Holdings, commonly known as Labcorp (NYSE: LH), is a global life sciences company that provides comprehensive clinical laboratory and drug development services. The company operates a broad network of laboratories, patient service centers and specialty testing sites to deliver diagnostic information and testing solutions that support patient care, clinical decision-making and population health initiatives.

Labcorp’s core businesses encompass clinical laboratory testing and pharmaceutical development services.

Read More

• Five stocks we like better than Labcorp
• Banks Are Buying Back Stock Hand Over Fist, Including These 3 Names
• 2 Aluminum Stocks Poised for Big Tariff-Related Gains
• AutoZone’s Pullback Sets Up a Long-Term Buying Opportunity
• AST SpaceMobile’s June Launch Plan Puts Its 2026 Satellite Goal Back in Focus

Receive News & Ratings for Labcorp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Labcorp and related companies with MarketBeat.com's FREE daily email newsletter.